Using fragment-based approaches to discover new antibiotics

Using fragment-based approaches to discover new antibiotics
Using fragment-based approaches to discover new antibiotics. Credit: Bas Lamoree and Roderick E. Hubbard

In the July 2018 issue of SLAS Discovery, a review article summarizes new methods of fragment-based lead discovery (FBLD) to identify new compounds as potential antibiotics.

Authors Bas Lamoree and Roderick E. Hubbard of the University of York (UK) explain how FBLD works and illustrate its advantages over conventional high-throughput screening (HTS). Specifically, how FBLD increases the chances of finding hit ; how its methods can deliver hits without the massive investment required for HTS; and how by starting small, FBLD gives medicinal chemists more opportunities to build more drug-like compounds. These principles are illustrated in the review and supported with recent examples of projects against a range of potential antibiotic targets.

The rise in is now recognized as a real threat to human health. However, no new have been developed in many decades. FBLD begins by identifying low molecular weight compounds (fragments), which bind to protein targets. Information on how the fragments bind to their protein targets is then used to grow the compounds into potent drug candidates. Because the fragments are small, they are more likely to fit into a binding site and each fragment represents a huge number of potential compounds.


Explore further

Microscale thermophoresis to characterize hits from high-throughput screening

More information: Bas Lamoree et al, Using Fragment-Based Approaches to Discover New Antibiotics, SLAS DISCOVERY: Advancing Life Sciences R&D (2018). DOI: 10.1177/2472555218773034
Provided by SLAS (Society for Laboratory Automation and Screening)
Citation: Using fragment-based approaches to discover new antibiotics (2018, June 21) retrieved 27 May 2019 from https://phys.org/news/2018-06-fragment-based-approaches-antibiotics.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
26 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more